Latera RCT - Latera vs. Sham Control for Lateral Nasal Valve Collapse

Clinical Trial Description

To evaluate the Latera Absorbable Nasal Implant (Latera Implant) Implant versus Sham Control in subjects with nasal valve collapse due to or primarily due to insufficient cartilaginous support of the lateral nasal wall. ;

Study Design

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT00837525` - Validity Study of a Nasal Valve Implant	N/A
Recruiting	`NCT05287841` - Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?	N/A
Completed	`NCT02188589` - Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse	N/A

See also

Status

Clinical Trial

Phase

Enrolling by invitation

NCT00837525 - Validity Study of a Nasal Valve Implant

N/A

Recruiting

NCT05287841 - Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?

N/A

Completed

NCT02188589 - Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03400787
Study type	Interventional
Source	Spirox, Inc.
Contact
Status	Completed
Phase	N/A
Start date	November 28, 2017
Completion date	December 23, 2020

Latera RCT - Latera vs. Sham Control for Lateral Nasal Valve Collapse

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms